148 related articles for article (PubMed ID: 3461455)
1. Hemostatic mechanisms, independent of platelet aggregation, arrest gastric mucosal bleeding.
Whittle BJ; Kauffman GL; Moncada S
Proc Natl Acad Sci U S A; 1986 Aug; 83(15):5683-7. PubMed ID: 3461455
[TBL] [Abstract][Full Text] [Related]
2. Haemostatic mechanism in the endometrium: role of cyclo-oxygenase products and coagulation factors.
Gelety TJ; Chaudhuri G
Br J Pharmacol; 1995 Mar; 114(5):975-80. PubMed ID: 7780653
[TBL] [Abstract][Full Text] [Related]
3. A new model to assess the haemorrhagic potential of various heparin preparations.
Berstad A; Bang CJ; Talstad I
Acta Chir Scand Suppl; 1990; 556():62-7. PubMed ID: 1963019
[TBL] [Abstract][Full Text] [Related]
4. Thromboxane A(2) synthase inhibitor enhanced antithrombotic efficacy of GPIIb-IIIa receptor antagonist without increasing bleeding.
Kawano KI; Hokamura K; Kondo K; Ikeda Y; Suzuki Y; Umemura K
Eur J Pharmacol; 2001 Apr; 417(3):217-22. PubMed ID: 11334853
[TBL] [Abstract][Full Text] [Related]
5. Gastric bleeding and increased gastric vascular permeability induced by platelet activating factor (PAF): effect of drugs that affect arachidonate metabolism.
Hatakeyama K; Yano S; Watanabe K
Jpn J Pharmacol; 1991 Jul; 56(3):271-7. PubMed ID: 1910120
[TBL] [Abstract][Full Text] [Related]
6. Effects of oxypolygelatin and dextran 70 on hemostatic variables in dogs.
Glowaski MM; Moon-Massat PF; Erb HN; Barr SC
Vet Anaesth Analg; 2003 Oct; 30(4):202-10. PubMed ID: 12925177
[TBL] [Abstract][Full Text] [Related]
7. Perioperative monitoring of primary and secondary hemostasis in coronary artery bypass grafting.
Hertfelder HJ; Bös M; Weber D; Winkler K; Hanfland P; Preusse CJ
Semin Thromb Hemost; 2005; 31(4):426-40. PubMed ID: 16149021
[TBL] [Abstract][Full Text] [Related]
8. The effect of inhibition of thromboxane synthesis in experimental thrombosis and hemostasis.
Bergqvist D; Björck CG; Dougan P; Esquivel CO; Lannerstad O; Nilsson B; Saldeen P; Saldeen T
Thromb Res; 1985 Feb; 37(3):435-48. PubMed ID: 3838828
[TBL] [Abstract][Full Text] [Related]
9. In vivo studies with the stabilized epoprostenol analogue taprostene. Effects on platelet functions and blood clotting.
Michel G; Seipp U
Arzneimittelforschung; 1990 Aug; 40(8):932-8. PubMed ID: 2242087
[TBL] [Abstract][Full Text] [Related]
10. The effect of serotonin inhibition on initial microvessel hemostasis and platelet aggregation in vivo.
Bergqvist D; Arvidsson S; Esquivel CO; Lindblad B; Haglund U
Thromb Haemost; 1983 Jun; 49(3):173-5. PubMed ID: 6879505
[TBL] [Abstract][Full Text] [Related]
11. The reduction of platelet thrombi on damaged vessel wall by a thromboxane synthetase inhibitor in rabbits.
Hall ER; Chen YC; Ho T; Wu KK
Thromb Res; 1982 Sep; 27(5):501-11. PubMed ID: 6891109
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of the buccal bleeding time and platelet glass bead retention as assays of hemostasis in the dog: the effects of acetylsalicylic acid, warfarin and von Willebrand factor deficiency.
Brassard JA; Meyers KM
Thromb Haemost; 1991 Feb; 65(2):191-5. PubMed ID: 2053106
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of platelet aggregation in baboons: therapeutic implications for xenotransplantation.
Alwayn IP; Appel JZ; Goepfert C; Buhler L; Cooper DK; Robson SC
Xenotransplantation; 2000 Nov; 7(4):247-57. PubMed ID: 11081759
[TBL] [Abstract][Full Text] [Related]
14. CGS 12970: a novel, long acting thromboxane synthetase inhibitor.
Ambler J; Butler KD; Ku EC; Maguire ED; Smith JR; Wallis RB
Br J Pharmacol; 1985 Oct; 86(2):497-504. PubMed ID: 2932197
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological characterization of FCE 27262, a combined thromboxane synthase inhibitor and PGH2/TXA2 receptor antagonist.
Vaghi F; Colombo M; Pierucci L; Volpi D; Dho L; Ukmar G; Rosa B; Salvati P
Drugs Exp Clin Res; 1993; 19(6):249-60. PubMed ID: 8013268
[TBL] [Abstract][Full Text] [Related]
16. Role of proaggregatory and antiaggregatory prostaglandins in hemostasis. Studies with combined thromboxane synthase inhibition and thromboxane receptor antagonism.
Gresele P; Arnout J; Deckmyn H; Huybrechts E; Pieters G; Vermylen J
J Clin Invest; 1987 Nov; 80(5):1435-45. PubMed ID: 2960694
[TBL] [Abstract][Full Text] [Related]
17. Effects of ketorolac tromethamine on hemostasis.
Greer IA
Pharmacotherapy; 1990; 10(6 ( Pt 2)):71S-76S. PubMed ID: 2082316
[TBL] [Abstract][Full Text] [Related]
18. Rapid Hemostatic Biomaterial from a Natural Bath Sponge Skeleton.
Wang Q; Chen J; Wang D; Shen M; Ou H; Zhao J; Chen M; Yan G; Chen J
Mar Drugs; 2021 Apr; 19(4):. PubMed ID: 33921176
[TBL] [Abstract][Full Text] [Related]
19. 1986: Pharmacological, hematological, and physiological effects of a new thromboxane synthetase inhibitor (CGS-13080) during cardiopulmonary bypass in dogs. Updated in 1994.
DeAnda A; Miller DC
Ann Thorac Surg; 1994 Mar; 57(3):778-80. PubMed ID: 7511885
[No Abstract] [Full Text] [Related]
20. Effects of dipyrone, meloxicam, or the combination on hemostasis in conscious dogs.
Zanuzzo FS; Teixeira-Neto FJ; Thomazini CM; Takahira RK; Conner B; Diniz MS
J Vet Emerg Crit Care (San Antonio); 2015; 25(4):512-20. PubMed ID: 26112345
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
